United States · FDA National Drug Code directory
Donepezil Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-778_b963d4b7-66f3-47d7-8671-7412d49e6cb3
- Product NDC
- 16571-778
- Form
- TABLET, FILM COATED
- Composition / generic term
- Donepezil Hydrochloride
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110531
- Source listing expiry
- 20261231
Source-listed ingredients
- DONEPEZIL HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (16571-778-03) · 16571-778-03
- 90 TABLET, FILM COATED in 1 BOTTLE (16571-778-09) · 16571-778-09
- 1000 TABLET, FILM COATED in 1 BOTTLE (16571-778-10) · 16571-778-10
- 500 TABLET, FILM COATED in 1 BOTTLE (16571-778-50) · 16571-778-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →